Description: 

This conference series gives clinicians an opportunity to stay up to date on the latest advances and recommendations in neurovascular care via review of emerging evidence in peer-reviewed journal articles. It also serves as a platform to share best practices with teammates across specialties, subspecialties, and service-lines. Additionally, this is a forum for clinicians to come together to discuss complex or rare patient cases and share various expertise so as to make informed decisions on the patients' treatment plan.

Target Audience: 

Nurse Practitioner (NP)

Nurse, Registered (RN)

Pharmacists (PharmD)

Physicians (MD or DO)

Physician Assistant (PA)

Social Workers

Learning Objectives: 

After Attending This Activity Learners Should Be Able To:

1. Discuss and review difficult neurovascular cases with team members of various specialties and disciplines to facilitate optimized care plan recommendations.

2. Adopt new evidence-based treatment options into practice based on review of peer-reviewed journal articles.

3. Discuss social determinants of health impacts on clinical presentation and/or implicit biases impacts on treatment planning.

Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):

Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:

Social Determinants of Health (SDOH)/Cultural or Linguistic Considerations:

• Amofa-Ho, P. A., Fiala, J. A., Levy, S. A., Marie Ross, K., Walker, A. F., & Smith, G. E. (2025). Interrelationships of Social Determinants with Cognition, Vascular Health, and Physical Functioning. Alzheimer's & dementia. Behavior & socioeconomics of aging, 1(2), e70013. https://doi.org/10.1002/bsa3.70013
• Olowoyo, P., Adeniji, O., Akinyemi, R., & Owolabi, M. (2024). Maintenance of brain health: The role of social determinants of health and other non-traditional cardiovascular risks. Cerebral circulation - cognition and behavior, 6, 100213. https://doi.org/10.1016/j.cccb.2024.100213
•  Towfighi, A., Berger, R. P., Corley, A. M. S., Glymour, M. M., Manly, J. J., & Skolarus, L. E. (2023). Recommendations on Social Determinants of Health in Neurologic Disease. Neurology, 101(7), S17-S26https://www.neurology.org/doi/10.1212/wnl.0000000000207562

Implicit Bias Considerations (as it relates to the content):       

• Vela MB, Erondu AI, Smith NA, Peek ME, Woodruff JN, Chin MH. Eliminating Explicit and Implicit Biases in Health Care: Evidence and Research Needs. Annu Rev Public Health. 2022 Apr 5;43:477-501.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172268/

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

Dr. Rudolph J. Schrot, faculty for this RSS has disclosed consulting relationships with SI-Bone involving education and product development, and professional services with Medtronic involving education. These relevant financial relationships have been reviewed and mitigated through clear role delineation. Dr. Schrot does not have independent control over case selection, content development, or clinical recommendations. Cases are selected and discussed by a multidisciplinary committee (that includes members without relevant financial relationships), ensuring balanced, evidence-based, and peer-informed perspectives.

Bahram Varjavand, MD has disclosed ownership of stock in Shape Memory Therapeutics. Because this activity uses a multidisciplinary case conference format, Dr. Varjavand will complete the Sutter Health Speaker Agreement and will refrain from discussing products or technologies related to Shape Memory Therapeutics during the educational activity. 

Matthew Alexander, faculty participant in this activity, receives consultant fees from Certus Critical Care, Route 92 Medical, Cerenovus Johnson & Johnson, and Medtronic. Dr. Alexandar also has an ownership interest in Wasatch Endovascular Solutions. These relevant ineligible relationships were mitigated via attestation of accreditation compliance via the Speaker Agreement Form and in compliance with Standard 3, Exception 2.

No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.   

– Provider Designee/Verification: Fozia Ferozali, Ed.D.